p17/p24:Ty-VLP HIV vaccine: The NIH's AIDS vaccine evaluation group began a Phase I trial to assess cellular immunity by killer T cells and levels of anti-HIV a

The trial will enroll 36 volunteers at low

Read the full 88 word article

How to gain access

Continue reading with a
two-week free trial.